BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2045470)

  • 1. Human plasma growth hormone (GH)-binding proteins are regulated by GH and testosterone.
    Postel-Vinay MC; Tar A; Hocquette JF; Clot JP; Fontoura M; Brauner R; Rappaport R
    J Clin Endocrinol Metab; 1991 Jul; 73(1):197-202. PubMed ID: 2045470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the short stature due to pubertal delay in boys.
    Adan L; Souberbielle JC; Brauner R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of growth hormone binding protein in a normal population and in subjects with short stature due to growth hormone resistance].
    Tar A; Postel-Vinay MC; Brauner R; Rappaport R
    Orv Hetil; 1992 Mar; 133(12):721-2, 727-30. PubMed ID: 1557221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM; Ramirez NR; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys.
    Martha PM; Rogol AD; Blizzard RM; Shaw MA; Baumann G
    J Clin Endocrinol Metab; 1991 Jul; 73(1):175-81. PubMed ID: 2045468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term testosterone treatment on leptin concentrations in boys with pubertal delay.
    Adan L; Bussières L; Trivin C; Souberbielle JC; Brauner R
    Horm Res; 1999; 52(3):109-12. PubMed ID: 10725773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration.
    Tar A; Hocquette JF; Souberbielle JC; Clot JP; Brauner R; Postel-Vinay MC
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1202-7. PubMed ID: 2229279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement.
    Veldhuis JD; Metzger DL; Martha PM; Mauras N; Kerrigan JR; Keenan B; Rogol AD; Pincus SM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3414-20. PubMed ID: 9329378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of testosterone on somatomedin-C concentrations in prepubertal boys.
    Parker MW; Johanson AJ; Rogol AD; Kaiser DL; Blizzard RM
    J Clin Endocrinol Metab; 1984 Jan; 58(1):87-90. PubMed ID: 6537787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.
    DiMartino-Nardi J; Wu R; Varner R; Wong WL; Saenger P
    J Clin Endocrinol Metab; 1994 Mar; 78(3):664-8. PubMed ID: 8126139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone.
    Olney RC; Prickett TC; Yandle TG; Espiner EA; Han JC; Mauras N
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4294-8. PubMed ID: 17684048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R; Prevot C; Brauner R
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen regulation of growth hormone binding protein.
    Keenan BS; Richards GE; Mercado M; Dallas JS; Eakman GD; Baumann G
    Metabolism; 1996 Dec; 45(12):1521-6. PubMed ID: 8969286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.